Walleye Capital’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74M | Buy |
+346,162
| New | +$4.74M | 0.02% | 405 |
|
|
2024
Q3 | – | Sell |
-57,610
| Closed | -$967K | – | 2891 |
|
|
2024
Q2 | $967K | Buy |
+57,610
| New | +$967K | ﹤0.01% | 1139 |
|
|
2024
Q1 | – | Sell |
-27,218
| Closed | -$408K | – | 2998 |
|
|
2023
Q4 | $408K | Buy |
+27,218
| New | +$408K | ﹤0.01% | 1231 |
|